Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 13;30(2):18.
doi: 10.5837/bjc.2023.018. eCollection 2023.

Diabetic cardiomyopathy: an educational review

Su-Lee Xiao  1 , Emilia Bober  2 , Xenophon Kassianides  3 , Francesco Medici  4 , Han B Xiao  5
Affiliations

Diabetic cardiomyopathy: an educational review

Su-Lee Xiao et al. Br J Cardiol. .

Abstract

This educational review provides information about the epidemiology of diabetes and heart failure (diabetic cardiomyopathy) and the challenges in diagnosis and screening. Details on how to investigate patients with imaging and other modalities are discussed, as well as an update regarding the efficacy and safety of novel agents for treatment of diabetic cardiomyopathy.

Keywords: diabetes; diabetic cardiomyopathy; heart failure.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest None declared.

Figures

Figure 1.
Figure 1.. A 12-lead ECG recorded in a 50-year-old woman showing sinus rhythm, borderline prolonged QRS duration (110 ms) and the absence of septal q wave
Figure 2.
Figure 2.. Echocardiograms recorded in parasternal long-axis view showing a non-dilated and poorly functioning left ventricle in a 36-year-old man who has been treated for type 2 diabetes and heart failure in comparison with images in a normal subject (51-year-old man)
See this image and copyright information in PMC

References

    1. Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81. doi: 10.1016/j.diabres.2018.02.023. - DOI - PubMed
    1. Gulsin GS, Athithan L, McCann GP. Diabetic cardiomyopathy: prevalence, determinants and potential treatments. Ther Adv Endocrinol Metab. 2019;10:1–21. doi: 10.1177/2042018819834869. - DOI - PMC - PubMed
    1. The Task Force on diabetes, prediabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2013;34:3035–87. doi: 10.1093/eurheartj/eht108. - DOI - PubMed
    1. Marwick TH, Ritchie R, Shaw JE, Kaye D. Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy. J Am Coll Cardiol. 2018;71:339–51. doi: 10.1016/j.jacc.2017.11.019. - DOI - PubMed
    1. Haas AV, McDonnell ME. Pathogenesis of cardiovascular disease in diabetes. Endocrinol Metab Clin N Am. 2018;47:51–63. doi: 10.1016/j.ecl.2017.10.010. - DOI - PubMed

LinkOut - more resources